TNGX Collar Strategy
TNGX (Tango Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.
TNGX (Tango Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $3.92B, a beta of 1.19 versus the broader market, a 52-week range of 4.8-34.39, average daily share volume of 3.9M, a public-listing history dating back to 2020, approximately 155 full-time employees. These structural characteristics shape how TNGX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.19 places TNGX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a collar on TNGX?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current TNGX snapshot
As of June 30, 2026, spot at $31.27, ATM IV 61.40%, IV rank 0.00%, expected move 17.60%. The collar on TNGX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this collar structure on TNGX specifically: IV regime affects collar pricing on both sides; compressed TNGX IV at 61.40% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 17.60% (roughly $5.50 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TNGX expiries trade a higher absolute premium for lower per-day decay. Position sizing on TNGX should anchor to the underlying notional of $31.27 per share and to the trader's directional view on TNGX stock.
TNGX collar setup
The TNGX collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TNGX near $31.27, the first option leg uses a $33.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TNGX chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TNGX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $31.27 | long |
| Sell 1 | Call | $33.00 | $1.30 |
| Buy 1 | Put | $30.00 | $0.90 |
TNGX collar risk and reward
- Net Premium / Debit
- -$3,087.00
- Max Profit (per contract)
- $213.00
- Max Loss (per contract)
- -$87.00
- Breakeven(s)
- $30.87
- Risk / Reward Ratio
- 2.448
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
TNGX collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on TNGX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$87.00 |
| $6.92 | -77.9% | -$87.00 |
| $13.84 | -55.8% | -$87.00 |
| $20.75 | -33.6% | -$87.00 |
| $27.66 | -11.5% | -$87.00 |
| $34.57 | +10.6% | +$213.00 |
| $41.49 | +32.7% | +$213.00 |
| $48.40 | +54.8% | +$213.00 |
| $55.31 | +76.9% | +$213.00 |
| $62.23 | +99.0% | +$213.00 |
When traders use collar on TNGX
Collars on TNGX hedge an existing long TNGX stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
TNGX thesis for this collar
The market-implied 1-standard-deviation range for TNGX extends from approximately $25.77 on the downside to $36.77 on the upside. A TNGX collar hedges an existing long TNGX position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current TNGX IV rank near 0.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on TNGX at 61.40%. As a Healthcare name, TNGX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TNGX-specific events.
TNGX collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TNGX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TNGX alongside the broader basket even when TNGX-specific fundamentals are unchanged. Always rebuild the position from current TNGX chain quotes before placing a trade.
Frequently asked questions
- What is a collar on TNGX?
- A collar on TNGX is the collar strategy applied to TNGX (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With TNGX stock trading near $31.27, the strikes shown on this page are snapped to the nearest listed TNGX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are TNGX collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the TNGX collar priced from the end-of-day chain at a 30-day expiry (ATM IV 61.40%), the computed maximum profit is $213.00 per contract and the computed maximum loss is -$87.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a TNGX collar?
- The breakeven for the TNGX collar priced on this page is roughly $30.87 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TNGX market-implied 1-standard-deviation expected move is approximately 17.60%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on TNGX?
- Collars on TNGX hedge an existing long TNGX stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current TNGX implied volatility affect this collar?
- TNGX ATM IV is at 61.40% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.